Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Greenwich LifeSciencesGLSI +0.84%35 FCF Yield % is -6.06 as of Aug. 08, 2026. GuruFocus rates GLSI with a GF Score™ of 35/100. The stock has 1 warning sign investors should review. Among 1,409 Biotechnology companies, Greenwich LifeSciences ranks better than 58.84% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Greenwich LifeSciences FCF Yield % Related Terms
Greenwich LifeSciences FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Greenwich LifeSciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Greenwich LifeSciences FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Greenwich LifeSciences's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Greenwich LifeSciences's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Greenwich LifeSciences (GLSI) has a FCF Yield % of -6.06 as of Aug. 08, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Greenwich LifeSciences and its competitors. According to the industry distribution chart, Greenwich LifeSciences ranks #580 out of 1409 companies in the Biotechnology industry, placing it in the top 41.2%.
Is Greenwich LifeSciences' FCF Yield % too high?
Greenwich LifeSciences' current FCF Yield % is -6.06. Based on the distribution chart, Greenwich LifeSciences ranks #580 out of 1409 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Greenwich LifeSciences has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Greenwich LifeSciences' FCF Yield % compare to PLX and DTIL?
According to the Biotechnology industry distribution chart, Greenwich LifeSciences ranks #580 out of 1409 companies for FCF Yield %. This puts Greenwich LifeSciences in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Greenwich LifeSciences and its competitors. Greenwich LifeSciences's current FCF Yield % is -6.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Greenwich LifeSciences stock overvalued right now?
Greenwich LifeSciences (GLSI) has a current FCF Yield % of -6.06. The current FCF Yield % is -6.06. Greenwich LifeSciences' overall GF Score™ is 35/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Greenwich LifeSciences (GLSI), the current FCF Yield % is -6.06 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.
35GF Score
Get the complete analysis for GLSI
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GLSI has been successfully added to your 
